LIVN
LivaNova PLC
$79.39
-0.69%
$4.4B
No data for this timeframe.
Vol
Market Cap$4.4B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (81%)
Insider Activity0B / 1S
Insider Net $-$136.3K
Reddit Sentiment50° Neutral
SEC Reports3
Exchange Nasdaq·Sector Electromedical & Electrotherapeutic Apparatus·Inc. X0·CIK 0001639691·Prev Close $79.94
Recent Activity
Jun 10, 2026
short_volume
Short Volume: LIVN — 84.8% short (0.6M / 0.7M)
Short: 600,662 | Exempt: 31,100 | TRF Vol: 708,499 | Short Ratio: 84.8% | Off-exchange volume (dark
May 26, 2026
Insider
Bianchi Francesco sold 1,800 shares
Director @ $75.75 ($136.3K)
May 6, 2026
SEC
LivaNova reported Q1 2026 revenue of $362.3M (+14.3% YoY reported, +11.1% constant-currency), beating consensus of $346.
8-K — Impact 8/10
Apr 29, 2026
SEC
LivaNova filed a definitive additional proxy soliciting material (DEFA14A) providing notice of its 2026 Annual General M
DEFA14A — Impact 2/10
Mar 30, 2026
Insider
Kozmina Natalia acquired via exercise 4,259 shares
Chief Human Resources Officer
Mar 30, 2026
Insider
Kozmina Natalia was granted 9,792 shares
Chief Human Resources Officer
Feb 25, 2026
SEC
LivaNova reported strong full-year 2025 results with double-digit revenue growth and improved margins, driven by both Ca
8-K — Impact 7/10
Price Targets
$80.60
+1.5% upside
Hold
Current $79.39
Low $67.00
Median $80.50
High $95.00
10 analysts
$67.00
$95.00
Analyst Ratings
6Strong Buy
7Buy
3Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 7, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
| May 7, 2026 | Mizuho | MAINTAIN | Outperform → Outperform |
| May 7, 2026 | Baird | MAINTAIN | Outperform → Outperform |
| Feb 27, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
| Feb 25, 2026 | Needham | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $1.09 | $1.06 — $1.13 | 4% YoY | 9 |
| Next Q | $1.08 ▼ -4.5% | $1.03 — $1.13 | -3% YoY | 9 |
| Current FY | $4.25 | $4.23 — $4.26 | 9% YoY | 9 |
| Next FY | $4.63 | $4.49 — $4.93 | 9% YoY | 9 |
Latest Reports
BULLISH
8-K
8/10
LivaNova reported Q1 2026 revenue of $362.3M (+14.3% YoY reported, +11.1% constant-currency), beating consensus of $346.
May 6, 2026
NEUTRAL
DEFA14A
2/10
LivaNova filed a definitive additional proxy soliciting material (DEFA14A) providing notice of its 2026 Annual General M
Apr 29, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 26, 2026 | Bianchi Francesco | SELL | $136.3K |
| Mar 30, 2026 | Kozmina Natalia | M | $0.00 |
| Mar 30, 2026 | Kozmina Natalia | A | $0.00 |
| Mar 30, 2026 | Kozmina Natalia | F | $84.2K |
| Mar 30, 2026 | Kozmina Natalia | A | $0.00 |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
7 unique insiders with 32 transactions. Net insider value: -$136.3K ($0.00 bought, $136.3K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 26, 2026 | Bianchi Francesco | Director | SELL | 1,800 | $75.75 | $136.3K |
| Mar 30, 2026 | Kozmina Natalia | Chief Human Resources Officer | EXERCISE | 4,259 | — | — |
| Mar 30, 2026 | Kozmina Natalia | Chief Human Resources Officer | AWARD | 9,792 | — | — |
| Mar 30, 2026 | Kozmina Natalia | Chief Human Resources Officer | TAX W/H | 1,374 | $61.27 | $84.2K |
| Mar 30, 2026 | Kozmina Natalia | Chief Human Resources Officer | AWARD | 3,264 | — | — |
| Mar 30, 2026 | Bolton Stephanie | President, Global Epilepsy | AWARD | 8,976 | — | — |
| Mar 30, 2026 | Kozmina Natalia | Chief Human Resources Officer | EXERCISE | 6,389 | — | — |
| Mar 30, 2026 | Bolton Stephanie | President, Global Epilepsy | EXERCISE | 17,815 | — | — |
| Mar 30, 2026 | Bolton Stephanie | President, Global Epilepsy | TAX W/H | 8,377 | $61.27 | $513.3K |
| Mar 30, 2026 | Bolton Stephanie | President, Global Epilepsy | EXERCISE | 457 | — | — |
| Mar 30, 2026 | Bolton Stephanie | President, Global Epilepsy | EXERCISE | 3,243 | — | — |
| Mar 30, 2026 | Bolton Stephanie | President, Global Epilepsy | AWARD | 2,992 | — | — |
| Mar 30, 2026 | Shvartsburg Alex | Chief Financial Officer | EXERCISE | 30,835 | — | — |
| Mar 30, 2026 | Shvartsburg Alex | Chief Financial Officer | AWARD | 16,321 | — | — |
| Mar 30, 2026 | Shvartsburg Alex | Chief Financial Officer | TAX W/H | 12,868 | $61.27 | $788.4K |
| Mar 30, 2026 | Shvartsburg Alex | Chief Financial Officer | EXERCISE | 914 | — | — |
| Mar 30, 2026 | Shvartsburg Alex | Chief Financial Officer | EXERCISE | 5,768 | — | — |
| Mar 30, 2026 | Poletti Franco | President, Cardiopulmonary | EXERCISE | 3,184 | — | — |
| Mar 30, 2026 | Poletti Franco | President, Cardiopulmonary | EXERCISE | 171 | — | — |
| Mar 30, 2026 | Makatsaria Vladimir | Chief Executive Officer | TAX W/H | 11,159 | $61.27 | $683.7K |
| Mar 30, 2026 | Shvartsburg Alex | Chief Financial Officer | AWARD | 5,440 | — | — |
| Mar 30, 2026 | Poletti Franco | President, Cardiopulmonary | TAX W/H | 1,370 | $61.27 | $83.9K |
| Mar 30, 2026 | Tezel Ahmet | Chief Innovation Officer | EXERCISE | 3,408 | — | — |
| Mar 30, 2026 | Makatsaria Vladimir | Chief Executive Officer | EXERCISE | 21,042 | — | — |
| Mar 30, 2026 | Makatsaria Vladimir | Chief Executive Officer | EXERCISE | 3,352 | — | — |
| Mar 30, 2026 | Makatsaria Vladimir | Chief Executive Officer | AWARD | 52,227 | — | — |
| Mar 30, 2026 | Tezel Ahmet | Chief Innovation Officer | AWARD | 13,873 | — | — |
| Mar 30, 2026 | Makatsaria Vladimir | Chief Executive Officer | AWARD | 17,409 | — | — |
| Mar 30, 2026 | Tezel Ahmet | Chief Innovation Officer | AWARD | 4,624 | — | — |
| Mar 30, 2026 | Tezel Ahmet | Chief Innovation Officer | TAX W/H | 1,186 | $61.27 | $72.7K |
| Mar 11, 2026 | Poletti Franco | President, Cardiopulmonary | EXERCISE | 2,140 | $57.60 | $123.3K |
| Mar 11, 2026 | Poletti Franco | President, Cardiopulmonary | TAX W/H | 1,980 | $62.26 | $123.3K |
3 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 5.7/10.
BULLISH
8-K
8/10
LivaNova reported Q1 2026 revenue of $362.3M (+14.3% YoY reported, +11.1% constant-currency), beatin
May 6, 2026
NEUTRAL
DEFA14A
2/10
LivaNova filed a definitive additional proxy soliciting material (DEFA14A) providing notice of its 2
Apr 29, 2026
BULLISH
8-K
7/10
LivaNova reported strong full-year 2025 results with double-digit revenue growth and improved margin
Feb 25, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (81% buy). Based on 16 analysts: 6 strong buy, 7 buy, 3 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$80.60 mean target
+1.5% upside
Hold (1.70)
$67.00 Low
$95.00 High
| Metric | Value |
|---|---|
| Current Price | $79.39 |
| Target Low | $67.00 |
| Target Mean | $80.60 |
| Target Median | $80.50 |
| Target High | $95.00 |
| # Analysts | 10 |
| Recommendation | Hold (1.70) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$1.09 | $1.06 | $1.13 | 3.9% | -0.1% | 4↑ 1↓ | $0.4B | 8.0% | 9 |
| Next Q 2026-09-30 |
$1.08 | $1.03 | $1.13 | -2.6% | -4.5% | 2↑ 5↓ | $0.4B | 6.3% | 9 |
| Current FY 2026-12-31 |
$4.25 | $4.23 | $4.26 | 8.9% | +0.1% | 8↑ 0↓ | $1.5B | 8.6% | 9 |
| Next FY 2027-12-31 |
$4.63 | $4.49 | $4.93 | 9.0% | -0.2% | 7↑ 1↓ | $1.6B | 7.0% | 9 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.091 | |
| 7d ago | $1.089 | +0.002 |
| 30d ago | $1.092 | -0.001 |
| 60d ago | $1.092 | -0.001 |
| 90d ago | $1.092 | -0.001 |
6 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 7, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| May 7, 2026 | Mizuho | MAINTAIN | Outperform | Outperform |
| May 7, 2026 | Baird | MAINTAIN | Outperform | Outperform |
| Feb 27, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 25, 2026 | Needham | MAINTAIN | Buy | Buy |
| Jan 9, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Jan 7, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Dec 19, 2025 | Keybanc | INITIATE | — | Overweight |
| Dec 17, 2025 | Mizuho | MAINTAIN | Outperform | Outperform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 6 | 7 | 3 | 0 | 0 | 81% | |
| May 1, 2026 | 6 | 7 | 4 | 0 | 0 | 76% | |
| Apr 1, 2026 | 6 | 7 | 4 | 0 | 0 | 76% | |
| Mar 1, 2026 | 6 | 7 | 4 | 0 | 0 | 76% | |
| Feb 1, 2026 | 6 | 7 | 4 | 0 | 0 | 76% | |
| Jan 1, 2026 | 6 | 7 | 4 | 0 | 0 | 76% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
1 mentions
0 bullish
0 bearish
1 time period
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Feb 25, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
Jun 10, 2026
short_volume
Short Volume: LIVN — 84.8% short (0.6M / 0.7M)
Short: 600,662 | Exempt: 31,100 | TRF Vol: 708,499 | Short Ratio: 84.8% | Off-exchange volume (dark pool + OTC)
May 27, 2026
short_volume
Short Volume: LIVN — 81.4% short (0.5M / 0.6M)
Short: 455,136 | Exempt: 129,700 | TRF Vol: 558,961 | Short Ratio: 81.4% | Off-exchange volume (dark pool + OTC)
May 13, 2026
short_interest
FTD: LIVN — 19,305 shares ($1.4M) failed to deliver
Settlement: 20260513, Price: $71.75, FTD Value: $1,385,133.75, LIVANOVA PLC SHS (GBR)
May 7, 2026
short_volume
Short Volume: LIVN — 61.4% short (0.4M / 0.7M)
Short: 447,973 | Exempt: 46,932 | TRF Vol: 729,351 | Short Ratio: 61.4% | Off-exchange volume (dark pool + OTC)
May 6, 2026
short_volume
Short Volume: LIVN — 65.4% short (0.7M / 1.1M)
Short: 698,868 | Exempt: 0 | TRF Vol: 1,068,522 | Short Ratio: 65.4% | Off-exchange volume (dark pool + OTC)
May 6, 2026
short_interest
FTD: LIVN — 18,361 shares ($1.1M) failed to deliver
Settlement: 20260506, Price: $57.59, FTD Value: $1,057,409.99, LIVANOVA PLC SHS (GBR)
May 6, 2026
earnings_calendar
LIVN Q1 2026 Earnings Before Market Open — 2026-05-06
Apr 30, 2026
short_volume
Short Volume: LIVN — 90.9% short (0.5M / 0.6M)
Short: 514,386 | Exempt: 0 | TRF Vol: 566,135 | Short Ratio: 90.9% | Off-exchange volume (dark pool + OTC)
Mar 31, 2026
short_volume
Short Volume: LIVN — 71.5% short (0.4M / 0.6M)
Short: 396,756 | Exempt: 0 | TRF Vol: 555,092 | Short Ratio: 71.5% | Off-exchange volume (dark pool + OTC)
Feb 25, 2026
earnings_calendar
LIVN Q4 2025 Earnings Before Market Open — 2026-02-25